Naltrexone stands as a beacon of hope for those navigating the rocky path to recovery. As an opioid antagonist, it serves a pivotal role in sustaining abstinence from opioid use. Its mode of action is non-narcotic — it binds to opioid receptors without causing the release of dopamine, hence preventing the ‘high’ associated with opioid use. Its two forms — the oral tablet (ReVia or Depade) and the monthly extended-release injection (Vivitrol) — provide flexible options for those committed to long-term sobriety. For individuals who have undergone the Waismann Method of rapid detox, naltrexone offers a subsequent layer of support, reinforcing the foundation laid by the initial detox process.
FDA Explores Approving OTC Naloxone Products
The U.S. Food and Drug Administration (FDA) has announced a potential pathway to allow naloxone hydrochloride, known by the name brand Narcan, to be…